Cargando…
Third-trimester tenofovir to prevent mother-to-child hepatitis B virus transmission
Autores principales: | Burman, Blaire E., Jhaveri, Manan A., Kowdley, Kris V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719592/ https://www.ncbi.nlm.nih.gov/pubmed/29168452 http://dx.doi.org/10.4103/ijmr.IJMR_315_17 |
Ejemplares similares
-
Participant perspectives to improve tenofovir adherence in the prevention of mother-to-child transmission of hepatitis B virus in Kinshasa, DRC
por: Morgan, Camille E., et al.
Publicado: (2023) -
Efficacy of antiviral therapy during the second or the third
trimester for preventing mother-to-child hepatitis B virus transmission: a
systematic review and meta-analysis
por: Yang, Xiuhan, et al.
Publicado: (2020) -
Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus
por: Zhu, Bo, et al.
Publicado: (2021) -
Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa
por: Mokaya, Jolynne, et al.
Publicado: (2019) -
New developments in the treatment of primary biliary cholangitis – role of obeticholic acid
por: Jhaveri, Manan A, et al.
Publicado: (2017)